An Adam15 amplification loop promotes vascular endothelial growth factor‐induced ocular neovascularization
Open Access
- 1 April 2008
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 22 (8) , 2775-2783
Abstract
Proteins with a disintegrin and a metalloproteinase domain (ADAMs) are a family of membrane‐bound proteinases that bind integrins through their disintegrin domain. In this study, we have found modest expression of ADAM15 in pericytes in normal retina and strong up‐regulation of ADAM15 in retinal vascular endothelial cells in ischemic retina. Increased expression of vascular endothelial growth factor (VEGF) in the retina in the absence of ischemia also increased ADAM15 levels, and knockdown of Vegf mRNA in ischemic retina reduced Adam15 mRNA. Mice deficient in ADAM15 showed a significant reduction in ischemia‐induced retinal neovascularization, choroidal neovascularization at rupture sites in Bruch's membrane, and VEGF‐induced subretinal neovascularization. ADAM15‐deficient mice also showed reduced levels of VEGF 164 , VEGF receptor 1, and VEGF receptor 2 in ischemic retina. These data suggest that ADAM15 and VEGF participate in an amplification loop; VEGF increases expression of ADAM15, which in turn increases expression of VEGF and its receptors. Perturbation of the loop by elimination of ADAM15 suppresses ocular neovascularization in 3 different model systems, and thus ADAM15 provides a new therapeutic target for diseases complicated by neovascularization.—Xie, B., Shen, J., Dong, A., Swaim, M., Hackett, S. F., Wyder, L., Worpenberg, S., Barbieri, S., Campochiaro, P. A. An Adam15 amplification loop promotes VEGF‐induced ocular neovascularization. FASEB J. 22, 2775–2783 (2008)Keywords
Funding Information
- Novartis (EY012609)
- National Eye Institute (P30EY1765)
This publication has 37 references indexed in Scilit:
- Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3Journal of Cell Biology, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Bevacizumab suppresses choroidal neovascularisation caused by pathological myopiaBritish Journal of Ophthalmology, 2005
- Up-regulation of Vascular Endothelial Growth Factor-A by Active Membrane-type 1 Matrix Metalloproteinase through Activation of Src-Tyrosine KinasesJournal of Biological Chemistry, 2004
- Potential Role for ADAM15 in Pathological Neovascularization in MiceMolecular and Cellular Biology, 2003
- Inducible Expression of Vascular Endothelial Growth Factor in Adult Mice Causes Severe Proliferative Retinopathy and Retinal DetachmentThe American Journal of Pathology, 2002
- Phosphorylation-dependent Interactions between ADAM15 Cytoplasmic Domain and Src Family Protein-tyrosine KinasesJournal of Biological Chemistry, 2002
- RETINAL ANGIOMATOUS PROLIFERATION IN AGE-RELATED MACULAR DEGENERATIONRetina, 2001
- Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor GenesJournal of Biological Chemistry, 1997
- Metargidin, a Membrane-anchored Metalloprotease-Disintegrin Protein with an RGD Integrin Binding SequenceJournal of Biological Chemistry, 1996